Biotech investors rejoice. The ASCO abstracts are here. The annual meeting of the American Society of Clinical Oncology starts on May 31, but the organization releases most of the 4,700 abstracts -- available...... (read more)

One of the major components of any sound buy-and-hold stock portfolio should be dividend yield.  A strong dividend suggests a company is financially solid and generating sufficient cash flow to maintain...... (read more)

Many stocks within the pharmaceutical industry have rallied significantly over the past few years and now sit at multi-year highs. It’s not hard to understand why: in today’s investing environment...... (read more)

Bristol Myers Squibb Co. (NYSE:BMY) – Shares in drug maker, Bristol Myers Squibb Co. (NYSE:BMY), are ripping higher today, up 6.5% at $44.94, the highest level in more than a decade, ahead of the release...... (read more)

Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2. The biotech announced earnings of $0.48 per share while analysts were expecting $0.50 per share...... (read more)

Pharmaceutical companies in the U.S. are not having it easy these days. When Johnson & Johnson (NYSE:JNJ) reported its latest numbers recently, it suffered from currency headwinds. Last week, Merck...... (read more)

Pfizer Inc. (NYSE:PFE) saw a strong pullback earlier this month, with its stock tumbling over 6% after reporting first-quarter earnings results. Meanwhile, fellow drug maker Merck & Co., Inc. (...... (read more)

As I noted nine weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing since 1991 thanks to access to more effective medications...... (read more)

The healthcare sector has been known for paying dependable dividends and producing strong total returns over time. Among the major pharmaceutical companies, there are a few that stand out as most financially...... (read more)